Donate

Publication Details

Need to talk? Call us free*
0800 808 00 00 7 days a week, 8am-8pm
Lenalidomide (Revlimid®)

Lenalidomide (Revlimid®) (January 2019)

Lenalidomide, also known as Revlimid®, is an immunomodulatory drug (IMiD) used in the treatment of myeloma.This factsheet describes what it is, how it works, how it is given, and possible side-effects.

Author(s)
Myeloma UK
Place of publication
Edinburgh
Publisher
Myeloma UK
Date of publication
January 2019
Pages
6pp
Series
Treatment guide
Supplier
https://www.myeloma.org.uk
Subject(s)
Myeloma, Immunomodulatory drugs, Lenalidomide, Revlimid®
Format
Factsheet
Language
English
Flesch readability score
48.5
Download this resource
Download this resource
Back to results
Need to talk? Call us free*
0800 808 00 00 7 days a week, 8am-8pm
Donate

About this site

Macmillan sites

Right there with you

We're here to provide physical, financial and emotional support. So whatever cancer throws your way, we're right there with you. Contact us

Follow us

© Macmillan Cancer Support 2019 © Macmillan Cancer Support, registered charity in England and Wales (261017), Scotland (SC039907) and the Isle of Man (604). Also operating in Northern Ireland. A company limited by guarantee, registered in England and Wales company number 2400969. Isle of Man company number 4694F. Registered office: 89 Albert Embankment, London SE1 7UQ. VAT no: 668265007